Vesugen — Vendor Pricing & Purity Guide
Research Overview
Vesugen is a synthetic tripeptide (Lys-Glu-Asp) bioregulator targeting vascular endothelium. Developed by Dr. Khavinson, it modulates gene expression in endothelial cells and has been studied for improving vascular function, particularly in age-related cardiovascular decline and atherosclerosis.
Vesugen promotes endothelial cell survival and function, supports vascular elasticity, and has demonstrated anti-atherogenic properties in preclinical models.
Key Research Findings
- •Improved endothelial cell function and vascular elasticity
- •Demonstrated anti-atherogenic properties in preclinical models
- •Modulated gene expression in vascular endothelial cells
- •Supported cardiovascular function in aging subjects
Research Dosage Protocols
Administered in 10-day courses of 10 mg daily, repeated 2-3 times annually.
For research reference only. Not medical advice. Not for human consumption.
Price Comparison (4 products from 4 vendors)
| Vendor | Price | Stock |
|---|---|---|
| Core Peptides | $63.00 $3.15/mg 20mg vial | In Stock |
| Soma Chems | $64.99 $3.25/mg 20mg vial | In Stock |
| Peptide Sciences | $65.00 $3.25/mg 20mg lyophilized | In Stock |
| BioLongevity Labs | $84.97 $4.25/mg 20mg vial | In Stock |
Frequently Asked Questions
What is Vesugen?
Vesugen is a tripeptide bioregulator targeting blood vessels. It supports endothelial function and vascular health, studied for age-related cardiovascular decline.